Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Gurus
Other
VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

Subscribe For Premium Access

VIVO CAPITAL, LLC

AUM: $5.81 B

13-F Portfolio Value: $1.20 B

Last 13-F Filed: Q1 2026

Concentration in top 10: 59.33%

Stock	Company	% Portfolio	Shares Held	Market Value	Change in Shares	% Change	Quarter End Price	Source
ABEO	Abeona Therapeutics, Inc.				-1,842,751	Exited		13F
CDTX	Cidara Therapeutics, Inc.				-956,670	Exited		13F
CTMX	Cytomx Therapeutics Inc				-2,884,615	Exited		13F
ENGNW	EnGene Holdings Inc				-285,046	Exited		13F
PALI	Palisade Bio Inc				-2,293,578	Exited		13F
SLN	Silence Therapeutics PLC				-1,105,454	Exited		13F
VSTM	Verastem Inc				-1,106,524	Exited		13F
ZBIO	Zenas Biopharma Inc				-853,495	Exited		13F
AVDL	Avadel Pharmaceuticals PLC				-2,684,109	Exited		13F